ADCT — ADC Therapeutics SA Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for ADC Therapeutics SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	R2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	20-F	20-F	10-K	10-K	10-K
Standards:	IFRS	IFRS	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	439	467	326	279	251
Net Total Accounts Receivable
Net Total Receivables	1.44	30.6	73	25.2	20.3
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	450	525	435	336	307
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	4.76	11.2	10.3	16.1	13.4
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	514	618	491	355	322
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	40.4	73.9	81.9	67.7	80.5
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Funded Status
Total Liabilities	178	452	411	503	525
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Other Equity
Total Equity	336	166	79.5	-148	-203
Total Liabilities & Shareholders' Equity	514	618	491	355	322
Total Common Shares Outstanding